Use and Costs for Tumor Gene Expression Profiling Panels in the Management of Breast Cancer From 2006 to 2012: Implications for Genomic Test Adoption Among Private Payers.
about
Breast cancer multigene testing trends and impact on chemotherapy use.Oncologist and organizational factors associated with variation in breast cancer multigene testing.Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.The Payer and Patient Cost Burden of Open Breast Conserving Procedures Following Percutaneous Breast Biopsy.
P2860
Use and Costs for Tumor Gene Expression Profiling Panels in the Management of Breast Cancer From 2006 to 2012: Implications for Genomic Test Adoption Among Private Payers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use and Costs for Tumor Gene E ...... Adoption Among Private Payers.
@en
type
label
Use and Costs for Tumor Gene E ...... Adoption Among Private Payers.
@en
prefLabel
Use and Costs for Tumor Gene E ...... Adoption Among Private Payers.
@en
P356
P1476
Use and Costs for Tumor Gene E ...... Adoption Among Private Payers
@en
P2093
Megan C Roberts
Stacie B Dusetzina
P304
P356
10.1200/JOP.2015.003624
P407
P577
2015-06-23T00:00:00Z